Mad in America: Rethinking Mental Health
Health & Fitness:Mental Health
In the face of the COVID pandemic, social and academic pressures, and an uncertain future, young people are struggling. Each week we see another news reports about a “mental health crisis” among youth in North America, including rising suicide rates. Last fall, a consortium of physicians declared poor youth mental health a “national emergency.” More recently, on December 7, 2021, the U.S. Surgeon General issued an advisory on Protecting Youth Mental Health, which prescribes actions by families, schools, governments, media and other stakeholders.
Typically, these announcements call for getting kids greater access to mental health diagnosis and treatment. As MIA readers know, that frequently leads to more screening, more labels, and more prescriptions for psychiatric drugs. In his practice with children and adolescents, his research, and his teaching, Dr. Elia Abi-Jaoude is pushing back on that approach in favor of alternatives that more closely involve families and take environmental elements into account. Here, he tell us why and shares how he works in his practice with youth in crisis.
Elia Abi-Jaoude, MD, FRCP(C) is a psychiatrist working mainly with children, adolescents, and their families at The Hospital for Sick Children in Toronto, Canada, primarily in an inpatient setting. He is also an assistant professor, researcher, and clinical educator at the University of Toronto.
Dr. Abi-Jaoude is interested in how social factors influence how we view the experiences of youth and in asking critical questions about some of psychiatry’s assumptions about diagnosis and treatment, particularly the influence of the pharmaceutical industry. He is coauthor of a journal article taking a second look at the research behind the famous Study 329, which found that certain psychiatric drugs did not improve teenagers’ depression symptoms better than no drugs, as had been claimed.
Leaving Biological Psychiatry Behind - An Interview With Rodrigo Nardi
Context and Care vs Isolate and Control - An Interview with Arthur Kleinman
Undisclosed Financial Conflicts of Interest in the DSM-5: An interview with Lisa Cosgrove and Brian Piper
Deprescribing Psychiatric Drugs to Reduce Harms and Empower Patients - Swapnil Gupta
Is Madness an Evolved Signal? – Justin Garson on Strategy Versus Dysfunction
'It Was a Joint Effort'- Deborah Kasdan on Bringing Her Late Sister's Story to Life
What if Much of What you Thought you Knew About Mental Health was up for Debate?
The Psychological Humanities Manifesto: An Interview with Mark Freeman
Robert Whitaker Answers Reader Questions on Pharma Marketing and Psychiatric Drugs
Robert Whitaker Answers Reader Questions on Mad in America, the Biopsychosocial Model, and Psychiatric History
The Making of a 'Madness' That Hides Our Monsters - An Interview with Audrey Clare Farley
A Playground for Predators-Diane Dimond on The Abuses of Guardianship
May Cause Side Effects–Radical Acceptance and Psychiatric Drug Withdrawal: An Interview with Brooke Siem
Branding Diseases: Ray Moynihan on How Drug Companies Market Psychiatric Conditions
How Mad Studies and the Psychological Humanities are Changing Mental Health: An Interview with Narrative Psychiatrist Bradley Lewis
Embracing the Shadow—Charlie Morley on Lucid Dreaming as Therapy
Family Panel Discussion – Supporting a Child, Teen, or Young Person in Crisis
Sacred Conversations: A Talk with Susan Swim and a Father Whose Daughter Found Healing
The Radical Politics of Madness-Micha Frazer-Carroll
Can Psychosocial Disability Decolonize Mental Health? A Conversation with Luis Arroyo and Justin Karter
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Mental Health Insights
MQ Open Mind
Speaking of Suicide
The Suicide Prevention Movement
Depression Talks Podcast